2nd Annual High Potent Medicines Conference
In-Person Event
May 29 - 30, 2018
Frankfurt, Hessen, DE
OVERVIEW
2nd Annual High Potent Medicines Conference is organized by MarketsandMarkets and will be held during May 29 - 30, 2018 at Dorint Hotel Main-Taunus-Zentrum Frankfurt / Sulzbach, Frankfurt, Hessen, Germany.
The target audience for this medical event is Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in the following departments - Research & Development, Manufacturing/Operations/Production, Maintenance, Engineering, Quality, Regulatory, Risk Assessments, Laboratory Services/Analytical, New Technologies, Process Development/Technical transfer, Environmental, Health & Safety (HSE), Occupational Toxicology, Industrial Hygiene, New Products, Product Quality, Innovations, Regulatory, Validation, Formulation Development, External Supply.
Conference Description :
The HPAPI industry is expanding at a healthy rate due to development and manufacturing of drugs for anti-cancer and chronic disorders. Despite of challenges in designing multiproduct facilities, robust containment, safety & toxicology issues, there are many pharmaceutical firms coming up with their new research pipeline of drugs.
The focus of this year’s conference would address the issues in process development, scale-up, regulatory updates, containment, handling, cleaning validation and toxicology of highly potent compounds. The conference would be discussing the latest industry trends, technological advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.
Conference Highlights :
• Aseptic processing and production of highly potent compounds.
• Risk management and monitoring scale-up processes for hipo products.
• Regulatory updates in GMP regulations.
• Changes in import regulations after USA-EU mutual recognition agreement.
• Requirements and strategies to ensure Data Integrity.
• Managing the risk of cross contamination of HPAPI’s.
• Robust and reliable containment solutions.
• Medical surveillance/monitoring workers programs.
• Cleaning Validation of highly potent products.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in the following departments - Research & Development, Manufacturing/Operations/Production, Maintenance, Engineering, Quality, Regulatory, Risk Assessments, Laboratory Services/Analytical, New Technologies, Process Development/Technical transfer, Environmental, Health & Safety (HSE), Occupational Toxicology, Industrial Hygiene, New Products, Product Quality, Innovations, Regulatory, Validation, Formulation Development, External Supply.
Conference Description :
The HPAPI industry is expanding at a healthy rate due to development and manufacturing of drugs for anti-cancer and chronic disorders. Despite of challenges in designing multiproduct facilities, robust containment, safety & toxicology issues, there are many pharmaceutical firms coming up with their new research pipeline of drugs.
The focus of this year’s conference would address the issues in process development, scale-up, regulatory updates, containment, handling, cleaning validation and toxicology of highly potent compounds. The conference would be discussing the latest industry trends, technological advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.
Conference Highlights :
• Aseptic processing and production of highly potent compounds.
• Risk management and monitoring scale-up processes for hipo products.
• Regulatory updates in GMP regulations.
• Changes in import regulations after USA-EU mutual recognition agreement.
• Requirements and strategies to ensure Data Integrity.
• Managing the risk of cross contamination of HPAPI’s.
• Robust and reliable containment solutions.
• Medical surveillance/monitoring workers programs.
• Cleaning Validation of highly potent products.
Additional details will be posted as soon as they are available.
KEY DATES
29 May, 2018
Event Start Date
30 May, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Dorint Hotel Main-Taunus-Zentrum Frankfurt / SulzbachRELATED CONFERENCES & LIVE WEBINARS
Quick Links